Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synthase inhibition

Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synthase inhibition

US Patent 11389452 · Granted Jul 19, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

[6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy2021
[6R]—MTHF—an efficient folate alternative in 5-fluorouracil based chemotherapy2021
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2020
Administration regime2019
Administration regime2019
[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy2019
[6R]-MTHF multiple bolus administration in 5-fluorouracil based chemotherapy2019
Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synth2019